| Term es nes pval sidak fdr geneset_size leading_edge leading_edge_size |
| Photodynamic therapyinduced nfe2l2 nrf2 survival signaling 0.8925175630881345 2.373326677805211 0.0176286645459504 0.9999763879682744 1.0 5 P07099,P09601,O15439 3 |
| Oxidation by cytochrome p450 0.8906142936905352 2.365420554437256 0.0180096068176243 0.999981283000778 1.0 5 O43169,Q16850 2 |
| Ketogenesis and ketolysis 0.818292202409136 2.2239151759590094 0.0261541518171255 0.9999998724618774 1.0 6 P23786,P35610,P53985,O43772 4 |
| Statin inhibition of cholesterol production 0.8749231714812544 2.137348108270282 0.0325696886782753 0.999999997566706 1.0 4 P35610,P37268,Q8WTV0 3 |
| Heme biosynthesis 0.8182472432001504 2.0595901518042523 0.0394377385014266 0.9999999999658976 1.0 5 P22830 1 |
| Relationship between inflammation cox2 and egfr 0.8553275500983324 2.056458213164459 0.0397383701232318 0.999999999971728 1.0 4 Q9H7Z7,P28482 2 |
| Apoptosis modulation by hsp70 0.7961233309645355 1.9640988175963616 0.0495186333233399 0.9999999999999386 1.0 5 O95831,Q13546 2 |
| Transcriptional activation by nrf2 in response to phytochemicals 0.8165784512603547 1.8946391681838688 0.0581402219593387 0.9999999999999998 1.0 4 P09601,P48507 2 |
| Il17 signaling pathway 0.8069453261909975 1.8540424047576607 0.063733093553951 1.0 1.0 4 P40763 1 |
| Methionine de novo and salvage pathway 0.7382910730356431 1.8505381187294183 0.064236029270646 1.0 1.0 7 Q13126 1 |
| Progeriaassociated lipodystrophy 0.746197913990636 1.8407999793449124 0.0656508758601612 1.0 1.0 10 O60725,O75844 2 |
| Pregnane x receptor pathway 0.7673326622426916 1.838501360372491 0.0659885615845747 1.0 1.0 5 P08183 1 |
| Il10 antiinflammatory signaling pathway 0.8016910740671662 1.8318404422117192 0.0669751959518336 1.0 1.0 4 P09601 1 |
| Endothelin pathways 0.7350193223790402 1.8196551023197105 0.0688115446559152 1.0 1.0 8 P16615,P42892,P28482 3 |
| Epo receptor signaling 0.7146351219938073 1.742083524368481 0.0814938300806171 1.0 1.0 7 P42224,P40763,P28482,Q15118 4 |
| Antiviral and antiinflammatory effects of nrf2 on sarscov2 pathway 0.7733220369001776 1.711281713602376 0.0870291203987916 1.0 1.0 4 P09601,P48507 2 |
| Vitamin a and carotenoid metabolism 0.7370153628220466 1.7047160957999767 0.0882473864406101 1.0 1.0 5 Q6NUM9,Q8WTV0 2 |
| Familial partial lipodystrophy fpld 0.7086877136324057 1.698274080701586 0.0894560443173313 1.0 1.0 8 O75844 1 |
| Sarscov2 and covid19 pathway 0.8598706485377857 1.669412709132364 0.0950356166500578 1.0 1.0 3 Q8WTV0 1 |
| Nanomaterial induced apoptosis 0.7287787588687691 1.6681183845608003 0.0952922282913135 1.0 1.0 5 Q07812,O95831 2 |
| Transcription factors regulate mirnas related to cardiac hypertrophy 0.8591577523190504 1.6665920168899828 0.0955955573619546 1.0 1.0 3 P40763 1 |
| Cholesterol biosynthesis with skeletal dysplasias 0.6925834166741305 1.6571853551516036 0.0974820064539261 1.0 1.0 6 Q16850 1 |
| Tca cycle nutrient use and invasiveness of ovarian cancer 0.8544138794090965 1.647810776814778 0.0993915068771738 1.0 1.0 3 P40763 1 |
| Cannabinoid receptor signaling 0.687437216080115 1.6333317775845633 0.1023992368581172 1.0 1.0 6 Q8NCG7,P45984,P28482,Q16539 4 |
| Cancer immunotherapy by pd1 blockade 0.8454685099846373 1.6123441281105038 0.1068870757152395 1.0 1.0 3 P40763,P04439 2 |
| Nrf2are regulation 0.6807400088677632 1.5849154580339846 0.1129855438884694 1.0 1.0 7 P09601,P48507 2 |
| Il7 signaling pathway 0.6766534244929301 1.583204722809114 0.1133748103730911 1.0 1.0 6 P40763,P28482 2 |
| Metabolism of spingolipids in er and golgi apparatus 0.737907377433207 1.559328870988878 0.1189185618065922 1.0 1.0 4 Q16739 1 |
| Pi3kaktmtor signaling pathway and therapeutic opportunities 0.6971787497177051 1.5268275804203828 0.1268038914226124 1.0 1.0 5 O43524 1 |
| Bile acids synthesis and enterohepatic circulation 0.8183758541085829 1.5045686070428674 0.1324350223569634 1.0 1.0 3 P28482 1 |
| Eicosanoid synthesis 0.8095238095238059 1.4692589866439605 0.1417625564957423 1.0 1.0 3 Q9H7Z7,P09960 2 |
| Il3 signaling pathway 0.6662680308817422 1.4676701716442466 0.1421938368674604 1.0 1.0 10 P40763,P28482,P46109 3 |
| Mrna protein and metabolite inducation pathway by cyclosporin a 0.8086106140222791 1.4656142189632533 0.1427534153534893 1.0 1.0 3 Q9UPY5 1 |
| Apoptosis modulation and signaling 0.6747307389334435 1.448972281486809 0.1473453235613802 1.0 1.0 14 O95831,Q13546,Q07812,P04632,O95817 5 |
| Striated muscle contraction pathway 0.6727838213507508 1.4169427634521516 0.1564996623895325 1.0 1.0 5 P28289 1 |
| Kisspeptinkisspeptin receptor system in the ovary 0.640371232623222 1.3954382137576042 0.1628837345314231 1.0 1.0 7 P28482,Q15118 2 |
| Influence of laminopathies on wnt signaling 0.6532642757730511 1.3903377330528723 0.1644263448665546 1.0 1.0 11 O75844 1 |
| Pdgfrbeta pathway 0.6425190335409379 1.388232141800696 0.1650663678498225 1.0 1.0 8 P42224,P19525,P40763 3 |
| S1p receptor signal transduction 0.637956097631014 1.3840392525932232 0.166346435952045 1.0 1.0 7 Q9H0H5,P28482 2 |
| Drug induction of bile acid pathway 0.9643734643734648 1.3774566258470728 0.1683711160572123 1.0 1.0 2 P08183 1 |
| Il2 signaling pathway 0.6451729985762147 1.367639437985819 0.1714249653547692 1.0 1.0 10 O43524,P28482,P46109,P40763 4 |
| Regulation of apoptosis by parathyroid hormonerelated protein 0.7822696336718855 1.3603566587181322 0.1737170867631101 1.0 1.0 3 Q07812 1 |
| Omega3 omega6 fatty acid synthesis 0.6206761815021151 1.3204129521811876 0.1866971815303693 1.0 1.0 6 Q15067,O60488,O95864 3 |
| Mammary gland development pathway involution stage 4 of 4 0.7720185902011529 1.3193578475055654 0.1870495069397457 1.0 1.0 3 P40763 1 |
| Type i interferon induction and signaling during sarscov2 infection 0.7665130568356342 1.2973385785199234 0.1945147159982512 1.0 1.0 3 P19525,Q7Z434 2 |
| Nephrotic syndrome 0.6379432717969769 1.286899168111051 0.1981294352949492 1.0 1.0 13 Q96D53,Q9BT22,O75844 3 |
| Sphingolipid metabolism overview 0.6197729996062677 1.2804415024271325 0.2003899056456006 1.0 1.0 8 Q16739,Q96G23 2 |
| Serotonin receptor 467 and nr3c signaling 0.6733101119146305 1.279332896699153 0.2007798528911142 1.0 1.0 4 P28482 1 |
| Imatinib and chronic myeloid leukemia 0.7567308804073674 1.2582246427881292 0.2083105252543391 1.0 1.0 3 O43524 1 |
| Kallmann syndrome 0.7508448540706572 1.2347006971016927 0.216941916364044 1.0 1.0 3 Q06124,P28482 2 |
| Hostpathogen interaction of human coronaviruses interferon induction 0.6025455185452645 1.2346487360328184 0.2169612624975798 1.0 1.0 6 P19525,Q7Z434,Q13546 3 |
| Estrogen receptor pathway 0.925675675675679 1.2326674364319927 0.2176998657222177 1.0 1.0 2 Q15067 1 |
| Heart development 0.7484352089653196 1.2250738437846904 0.2205473991821305 1.0 1.0 3 P28482 1 |
| Selenium micronutrient network 0.6142580780443421 1.2203660456520078 0.2223261429804495 1.0 1.0 10 Q8WTV0 1 |
| Sphingolipid metabolism integrated pathway 0.6099424549150352 1.2165218761052228 0.2237861827866099 1.0 1.0 9 Q16739,Q96G23 2 |
| Inhibition of exosome biogenesis and secretion by manumycin a in crpc cells 0.6067292006139364 1.2012198468073991 0.2296659326579597 1.0 1.0 9 P61020,P28482,P31943 3 |
| Mitochondrial complex iv assembly 0.6282440813787888 1.1979013404102703 0.2309554278802124 1.0 1.0 16 P13073,P14406,Q7KZN9,P09669,P14854,Q9Y241,Q8N8Q8,Q9Y2R0 8 |
| Type i collagen synthesis in the context of osteogenesis imperfecta 0.6145243002503976 1.1896701594243295 0.2341760583588339 1.0 1.0 12 O15460,P07237,P13674 3 |
| Cell differentiation expanded index 0.9087837837837848 1.1697976931306642 0.2420823922413184 1.0 1.0 2 P40763 1 |
| Tgfbeta receptor signaling 0.5839609155946365 1.1466195559392791 0.2515388905121449 1.0 1.0 6 P42224,P40763 2 |
| Tgfbeta receptor signaling in skeletal dysplasias 0.5839609155946365 1.1466195559392791 0.2515388905121449 1.0 1.0 6 P42224,P40763 2 |
| Tgfbeta signaling in thyroid cells for epithelialmesenchymal transition 0.6409134991807208 1.13854488405995 0.2548930279729215 1.0 1.0 4 P08670 1 |
| Allograft rejection 0.5973714021507173 1.1233758624342338 0.2612778967478601 1.0 1.0 11 P08183,P04439,P10321,P01889,P08670 5 |
| Hepatocyte growth factor receptor signaling 0.5845292907534029 1.095505069678911 0.2732954257046462 1.0 1.0 9 P40763,P28482,P46109 3 |
| Hostpathogen interaction of human coronaviruses apoptosis 0.7128215358758291 1.083217506416001 0.2787118910259993 1.0 1.0 3 Q07812 1 |
| Cytosolic dnasensing pathway 0.5826762033384263 1.06968893374505 0.2847593491163309 1.0 1.0 10 Q7Z434,Q13546 2 |
| Regucalcin in proximal tubule epithelial kidney cells 0.594060808187268 1.060335044405001 0.2889922015387616 1.0 1.0 5 Q07812 1 |
| Novel intracellular components of rigilike receptor rlr pathway 0.5798925318694106 1.0564259170924055 0.2907736704557178 1.0 1.0 10 Q7Z434,Q13546 2 |
| Overview of nanoparticle effects 0.8780712530712593 1.0563486298478462 0.2908089661344673 1.0 1.0 2 P09601 1 |
| Neovascularisation processes 0.7022695909823534 1.04142423178636 0.2976787011351218 1.0 1.0 3 P28482 1 |
| Overlap between signal transduction pathways contributing to lmna laminopathies 0.595286795947202 1.0383437022669515 0.299110069451229 1.0 1.0 16 Q9Y2U8,P50402,O75844,O60725,P11802,P42166,P42167,P55209 8 |
| Aspirin and mirnas 0.870393120393126 1.0282113113550675 0.3038504387653598 1.0 1.0 2 O15439 1 |
| Sarscov2 innate immunity evasion and cellspecific immune response 0.5737293182402913 1.0270835142484025 0.3043811407310099 1.0 1.0 10 Q14258,Q7Z434,Q13546 3 |
| Genes related to primary cilium development based on crispr 0.5753256289818279 0.986328839326662 0.3239717722384916 1.0 1.0 13 O95684,Q10713 2 |
| Proximal tubule transport 0.5592925754787137 0.9418451953279808 0.3462719022971909 1.0 1.0 11 P38606,P11166,P08183,O15439 4 |
| Praderwilli and angelman syndrome 0.5439007966981756 0.938737114057158 0.3478657331407431 1.0 1.0 7 Q15154,Q00534,Q05086 3 |
| Riboflavin and coq disorders 0.539685364437269 0.937512399595114 0.3484950485734086 1.0 1.0 6 Q8NFF5 1 |
| Angiotensin ii receptor type 1 pathway 0.6682004245076979 0.9077378863122848 0.3640167221597137 1.0 1.0 3 P28482 1 |
| Sarscov2 b117 variant antagonises innate immune activation 0.8329238329238389 0.8926635330170831 0.3720373847482059 1.0 1.0 2 Q7Z434 1 |
| Tryptophan metabolism 0.5551128934293258 0.8598336846405763 0.3898807281556706 1.0 1.0 15 P40939,P51648,Q15392,P35610,P05091 5 |
| Onecarbon metabolism and related pathways 0.5482145418268386 0.8573546101727215 0.3912489362414892 1.0 1.0 13 P35790,O43865,P48507 3 |
| P53 transcriptional gene network 0.5418051649378812 0.8429297447226798 0.3992677369042725 1.0 1.0 12 Q7LG56,Q9UPY5,Q07812,Q9NQ88,P11166,P04066 6 |
| Il9 signaling pathway 0.5216584107265332 0.8346251821265903 0.4039287790196262 1.0 1.0 7 P42224,P40763,P28482 3 |
| Amyotrophic lateral sclerosis als 0.5326685607568855 0.8330576732703533 0.4048122034690553 1.0 1.0 10 P07197,P07196,Q07812,P20339 4 |
| Sphingolipid pathway 0.5347046613358272 0.8258586927894946 0.4088842550689358 1.0 1.0 11 Q16739 1 |
| 4hydroxytamoxifen dexamethasone and retinoic acids regulation of p27 expression 0.5157558479446325 0.8257571633609556 0.4089418582603685 1.0 1.0 6 P28482 1 |
| Physiological and pathological hypertrophy of the heart 0.5217702670763245 0.8170501740556392 0.4138997554536601 1.0 1.0 8 P40763 1 |
| Neural crest cell migration during development 0.5120877906588885 0.8087625175344944 0.4186517600764974 1.0 1.0 6 P40763 1 |
| Mitochondrial complex iii assembly 0.5233817381748769 0.8069112705545136 0.4197176049885882 1.0 1.0 9 Q6DKK2,P31930,Q9UDW1,P22695 4 |
| 16p112 distal deletion syndrome 0.5180860689827307 0.7999416076262741 0.4237446295118166 1.0 1.0 8 Q9H2V7,Q8WWM7 2 |
| Serotonin htr1 group and fos pathway 0.5166744352350213 0.7933982679861598 0.4275458195445165 1.0 1.0 8 P28482,Q02750,Q16539,P16220 4 |
| Tlr4 signaling and tolerance 0.6342490003808113 0.7773567330389861 0.4369483318722724 1.0 1.0 3 Q13546 1 |
| Angiogenesis 0.6331797235022983 0.7733119742076078 0.4393377709020782 1.0 1.0 3 Q16539,P28482 2 |
| Sphingolipid metabolism in senescence 0.5325245476683514 0.7681526031525496 0.4423965282871573 1.0 1.0 14 Q16739,Q96G23 2 |
| Regulatory circuits of the stat3 signaling pathway 0.5133094168287612 0.7430899657220535 0.4574272142786304 1.0 1.0 10 Q96B36,P40763 2 |
| Ferroptosis 0.5514426941525936 0.7391634802273586 0.4598077336750805 1.0 1.0 23 Q9UPY5,P45880,P37268,P16435,Q9Y277,P48507,Q9UKU0,P09601,Q9NZZ3,Q9NZ45,P08195 11 |
| Wnt signaling in kidney disease 0.5467226370211185 0.7374936619227429 0.4608221961348828 1.0 1.0 4 O14641 1 |
| Apoptosis 0.5147247882380362 0.7329259504898219 0.4636035945195123 1.0 1.0 11 Q07812,Q13546 2 |
| Leptininsulin signaling overlap 0.7837837837837921 0.7211042168227224 0.4708453968037935 1.0 1.0 2 P40763 1 |
| Tnfrelated weak inducer of apoptosis tweak signaling pathway 0.5151652982194115 0.7187092822686344 0.4723200628762938 1.0 1.0 12 P31751,P28482,Q13546 3 |
| Folatealcohol and cancer pathway hypotheses 0.6174193227543263 0.7142225927817305 0.4750895485929369 1.0 1.0 3 P16220 1 |
| Intracellular trafficking proteins involved in cmt neuropathy 0.5012104472638543 0.704687479359963 0.4810047448474912 1.0 1.0 9 Q9NR77,O95140 2 |
| Neural crest differentiation 0.4972318539470245 0.6865680712489448 0.4923549545694707 1.0 1.0 9 Q9NR77 1 |
| Nocgmppkg mediated neuroprotection 0.4881663726855127 0.6808342801892278 0.4959763564002928 1.0 1.0 7 P30536 1 |
| Glutathione metabolism 0.4827050312541643 0.6744838424458222 0.5000037546967402 1.0 1.0 6 P11413,P48507 2 |
| Eicosanoid metabolism via lipooxygenases lox 0.482682684937811 0.6743832212177019 0.5000677072595998 1.0 1.0 6 Q15067 1 |
| Vitamin d metabolism 0.60617041839979 0.672715970364878 0.5011280053957836 1.0 1.0 3 P38435 1 |
| Map3k1 role in promoting and blocking gonadal determination 0.5060921059350096 0.6712664419595379 0.5020508086507629 1.0 1.0 5 P28482 1 |
| Ccl18 signaling pathway 0.4967155821053821 0.6671936782129398 0.5046484286770547 1.0 1.0 10 P11166,P08670,Q86UE4,P07196 4 |
| Nonsmall cell lung cancer 0.5230417435360165 0.6667455032419743 0.5049347080440096 1.0 1.0 18 Q15118,P31751,O43524,Q00534,P62993,Q07812,P40763,P28482 8 |
| Sars coronavirus and innate immunity 0.7662776412776512 0.6623110081805147 0.5077719233488316 1.0 1.0 2 Q7Z434 1 |
| Endometrial cancer 0.5080905089292715 0.6550843777085681 0.5124134297525873 1.0 1.0 14 O43524,P28482,Q07812 3 |
| Cholesterol biosynthesis pathway 0.4992522621179705 0.6459473530994165 0.5183134512387015 1.0 1.0 12 Q14534,Q16850,P37268 3 |
| Tolllike receptor signaling pathway 0.4926850097144674 0.6324229291166881 0.5271105550262976 1.0 1.0 11 Q13546,Q9H0E2,P31751,P45984,P42224,P28482 6 |
| Nrp1triggered signaling pathways in pancreatic cancer 0.4708706063241527 0.6215862210350379 0.5342139836818094 1.0 1.0 6 P28482 1 |
| Il5 signaling pathway 0.4919381796530789 0.6129662166439143 0.5398986780230626 1.0 1.0 12 O43524,P40763,Q06124,P42224,P28482 5 |
| Congenital generalized lipodystrophy cgl 0.7506142506142572 0.6109931126870216 0.5412041398993179 1.0 1.0 2 P31751 1 |
| Prion disease pathway 0.4798435373526933 0.6083746951840475 0.5429389906122934 1.0 1.0 9 P28482,P40763,P16220 3 |
| Purine metabolism and related disorders 0.4964816768790528 0.5875997301740036 0.5568009921988875 1.0 1.0 15 P00813,Q7LG56 2 |
| Resistin as a regulator of inflammation 0.4631041950037212 0.5873375816690324 0.556977005592231 1.0 1.0 6 P28482 1 |
| Folate metabolism 0.4884177227130856 0.5663803975127384 0.5711352174168693 1.0 1.0 14 Q8NFF5,Q8WTV0 2 |
| Embryonic stem cell pluripotency pathways 0.477234797856961 0.5322157521369036 0.5945765742561244 1.0 1.0 13 P31751,P40763,P28482,O14641 4 |
| Erk pathway in huntingtons disease 0.4948633462478133 0.5315434777462582 0.5950422209821902 1.0 1.0 4 P55210,P28482 2 |
| Hepatitis c and hepatocellular carcinoma 0.4649093418234806 0.526147908283685 0.5987854441018601 1.0 1.0 10 Q06124,P55210,P62993,P40763 4 |
| Vitamin d receptor pathway 0.4716224282565852 0.5232177079802526 0.6008227598815166 1.0 1.0 12 Q96KA5,P11413,P08183 3 |
| Nongenomic actions of 125 dihydroxyvitamin d3 0.4560189647613855 0.5044815397706514 0.6139230313053394 1.0 1.0 9 P28482,P45984,P42224,Q16539 4 |
| Cellular proteostasis 0.4870928088506482 0.5022957371570161 0.6154595073752542 1.0 1.0 4 P61758,O15212,Q9UHV9 3 |
| Kit receptor signaling pathway 0.4835435478482841 0.501851213267259 0.6157721852644633 1.0 1.0 17 O43524,P40763,P46109,Q06124,P42224,P51812,P28482 7 |
| Mevalonate arm of cholesterol biosynthesis pathway 0.4561222078536998 0.4884952831775591 0.6251990659162308 1.0 1.0 10 P35610 1 |
| Il4 signaling pathway 0.4505802674657418 0.4814013749028774 0.6302312597003938 1.0 1.0 9 P62993,P40763,Q06124,P42224,P28482 5 |
| Mitochondrial long chain fatty acid betaoxidation 0.4663418105202373 0.4701610388983778 0.6382399675739379 1.0 1.0 14 P23786,P49748,O43772 3 |
| Canonical and noncanonical tgfb signaling 0.7042383292383279 0.4676783614550933 0.6400146175314416 1.0 1.0 2 P45984 1 |
| Adipogenesis 0.4719927922483735 0.4518665284700172 0.6513651387419042 1.0 1.0 17 O14654,P16220,O75844,Q9NR56,P40763,P14174,Q9NZ45 7 |
| Burn wound healing 0.4391627002987049 0.4503004585545375 0.6524938084044261 1.0 1.0 8 Q99439 1 |
| Il6 signaling pathway 0.4492344361237158 0.4436220043529659 0.6573158940586663 1.0 1.0 11 Q06124,P42224,P40763,P28482 4 |
| Ciliopathies 0.4686808723959991 0.4244268236852192 0.6712545618272798 1.0 1.0 18 Q9ULC3,Q99570,Q10713,Q7Z4L5,Q9NQH7,Q01968,Q9UBB4,Q8TD19,Q13432,Q9BW83 10 |
| Fluoroacetic acid toxicity 0.4439409164395881 0.420043890461091 0.6744533908977914 1.0 1.0 5 P51648 1 |
| Egfr tyrosine kinase inhibitor resistance 0.4633748750892636 0.4021361769516183 0.6875838096161941 1.0 1.0 18 O43524,P28482,Q07812,P40763 4 |
| Thymic stromal lymphopoietin tslp signaling pathway 0.4407936613775934 0.3936713440655741 0.6938237005696255 1.0 1.0 12 Q9BTU6,P45984,P40763,Q06124,P42224,P28482 6 |
| Serotonin and anxiety 0.5231950844853991 0.3911179057652231 0.6957100858556151 1.0 1.0 3 Q06787,P05771 2 |
| Estrogen signaling pathway 0.4142576859884903 0.3832725877185927 0.7015176621013848 1.0 1.0 6 P45984,P28482,P16220 3 |
| Photodynamic therapyinduced hif1 survival signaling 0.4298299643478239 0.3802226110547975 0.7037801762289471 1.0 1.0 10 P11166,P17858,P53985 3 |
| Metapathway biotransformation phase i and ii 0.4682801202404746 0.3732368526051559 0.708972170243567 1.0 1.0 22 O14880,Q99735,P07099,Q16850,Q8NCH0 5 |
| Interferon type i signaling pathways 0.449400295760983 0.3713432572306798 0.7103818829265096 1.0 1.0 16 Q53EL6,P46109 2 |
| Nrf2 pathway 0.4617628725605082 0.3700964493651252 0.7113106275835241 1.0 1.0 20 O14880,Q99735,P48507,P09601,O15439,P11166 6 |
| Factors and pathways affecting insulinlike growth factor igf1akt signaling 0.4187887396539775 0.368239648957275 0.712694548611212 1.0 1.0 8 Q96B36 1 |
| Regulation of sister chromatid separation at the metaphaseanaphase transition 0.4202280299032148 0.3580201683192717 0.7203282204729704 1.0 1.0 9 O43683 1 |
| Aryl hydrocarbon receptor pathway wp2873 0.4455346091674341 0.3556364390148847 0.7221128510203185 1.0 1.0 4 Q07812 1 |
| Copper homeostasis 0.4155480472622332 0.3556273571092649 0.7221196532854515 1.0 1.0 8 O43524 1 |
| Neural crest cell migration in cancer 0.4151184250825958 0.3539651029138977 0.7233650361377235 1.0 1.0 8 P40763 1 |
| Target of rapamycin tor signaling 0.4228158924392725 0.352622439969888 0.7243715122685055 1.0 1.0 10 Q6PHR2 1 |
| Mapk cascade 0.4008932432233111 0.3318375249743793 0.7400119474199478 1.0 1.0 6 P28482,P62993 2 |
| Hepatitis b infection 0.4555148598195291 0.2986377309796221 0.7652164732722435 1.0 1.0 24 P16220,P31751,Q9Y277,P62993,Q07812,Q7Z434,P45984,P40763,P42224,P28482 10 |
| Dna damage response only atm dependent 0.4552760096585527 0.2976835766656224 0.7659446793908915 1.0 1.0 24 Q15118,O14641,O43524,Q07812,Q13362,P28482,Q16537 7 |
| Transsulfuration pathway 0.3916966829722678 0.2822273378691984 0.7777691974106498 1.0 1.0 7 P48507 1 |
| Transcription factor regulation in adipogenesis 0.6317567567567626 0.2774888699683168 0.7814047508841806 1.0 1.0 2 P16220 1 |
| Valproic acid pathway 0.3846794972417973 0.272661197724431 0.7851136645712504 1.0 1.0 6 P40939 1 |
| Wnt signaling pathway and pluripotency 0.4336766855674059 0.2591923466254546 0.7954868358941107 1.0 1.0 20 P25054,O14641,Q9H0H5,P63151,P30153,Q13362,Q16537 7 |
| Met in type 1 papillary renal cell carcinoma 0.4172760690819928 0.235268680854487 0.8140002019882309 1.0 1.0 17 P31751,P40763,P28482,P46109 4 |
| Tcell activation sarscov2 0.4026829437182649 0.2351039704858673 0.8141280370601147 1.0 1.0 13 O43524,Q07812 2 |
| Tyrobp causal network in microglia 0.3727278735968592 0.231566007844733 0.8168751117104935 1.0 1.0 6 O15439 1 |
| Pilocytic astrocytoma 0.4627714779063842 0.2261534370830736 0.8210820842251001 1.0 1.0 3 Q06124 1 |
| Tnfalpha signaling pathway 0.4213165917474873 0.2255714671337689 0.8215347348240953 1.0 1.0 19 P28482,P55210,Q13546,P62993,Q07812,P45984,Q13616,Q16543,P53350 9 |
| Cholesterol metabolism with bloch and kandutschrussell pathways 0.4306758768222999 0.2038431594939606 0.838476064467073 1.0 1.0 24 P37268,O95864,Q15392,P35610,P48449,O60488,Q14534,Q16850 8 |
| Tcell antigen receptor tcr pathway during staphylococcus aureus infection 0.3886606359203013 0.2006183294290209 0.8409970246415672 1.0 1.0 12 P11802,P62993,Q9UHD1,Q15118 4 |
| Erbb signaling pathway 0.4033155938203477 0.1988611881072373 0.8423713305059735 1.0 1.0 16 P28482,P46109 2 |
| Acute viral myocarditis 0.3970686845568759 0.1779867780299858 0.8587333595481845 1.0 1.0 16 P55210,P16220,Q07812,P40763,P28482 5 |
| Pyrimidine metabolism and related diseases 0.3622080995384485 0.1697038873561278 0.86524301675205 1.0 1.0 8 Q7LG56,Q05682 2 |
| Mbdnf and probdnf regulation of gaba neurotransmission 0.3580283025486848 0.157122250483276 0.8751485020292966 1.0 1.0 8 P40763,P16220,P63010 3 |
| Alzheimers disease 0.4015121545708217 0.1543857541686719 0.8773055855191629 1.0 1.0 89 P45880,P28072,P49721,Q99436,P21796,Q16186,O00213,P60900,P28482,P17655,Q99714,P31751,P28070,Q9BVA1,P19525,Q07866,P16615,P55210,Q9Y277,Q9H0B6,O95197,P28074,Q9BUF5,O14641 24 |
| Hostpathogen interaction of human coronaviruses mapk signaling 0.3560538357708026 0.1512912040592348 0.8797460075613259 1.0 1.0 8 P45984,P51812,P28482 3 |
| Alzheimers disease and mirna effects 0.3973646947532839 0.1503070769723512 0.8805223498057453 1.0 1.0 90 P45880,P28072,P49721,Q99436,P21796,Q16186,O00213,P60900,P28482,P17655,Q99714,P31751,P28070,Q9BVA1,P19525,Q07866,P16615,P55210,Q9Y277,Q9H0B6,O95197,P28074,Q9BUF5,O14641 24 |
| Transsulfuration and onecarbon metabolism 0.3901734531402623 0.1441370505417729 0.8853922480823844 1.0 1.0 17 O43175,O43865 2 |
| Tolllike receptor signaling related to myd88 0.4234566551897916 0.1433423966176412 0.8860197738736875 1.0 1.0 3 P28482 1 |
| Il1 signaling pathway 0.3658739626180309 0.1420111419913257 0.8870712048494376 1.0 1.0 11 Q9BQ95,Q16539,Q9H0E2,P19174,P45984,Q06124,P28482 7 |
| Mapk pathway in congenital thyroid cancer 0.5595823095823177 0.1407546324444464 0.8880637842177488 1.0 1.0 2 Q02750 1 |
| Fgfr3 signaling in chondrocyte proliferation and terminal differentiation 0.3428659560849127 0.139533464457991 0.8890286137690615 1.0 1.0 6 P42224,P28482 2 |
| Interleukin11 signaling pathway 0.3673328838233712 0.1340323523750447 0.8933769917460124 1.0 1.0 12 P16220,P40763,Q06124,P42224,P28482 5 |
| Nanoparticlemediated activation of receptor signaling 0.3450938486229712 0.1328464774148385 0.8943147964243146 1.0 1.0 7 P45984,P28482,P62993 3 |
| Fatty acid betaoxidation 0.3978722116699162 0.12442946570718 0.9009752443713466 1.0 1.0 21 P35610,P23786,P49748,O43772 4 |
| 15q112 copy number variation syndrome 0.3567916410571634 0.1183675931647087 0.9057764021374868 1.0 1.0 4 Q96CW5,Q06787,Q9BSJ2 3 |
| Interactions between loxl4 and oxidative stress pathway 0.3558696988322098 0.1165601417159036 0.9072086246563884 1.0 1.0 4 Q96EB6,Q9BQ95,Q16543 3 |
| Synaptic signaling pathways associated with autism spectrum disorder 0.3567889274955798 0.1159787363052215 0.9076693940267566 1.0 1.0 11 Q05086,P28482 2 |
| Mitochondrial complex i assembly model oxphos system 0.4174997534204276 0.1107082711194412 0.9118476868979803 1.0 1.0 29 Q9NPL8,P03886,Q9H845,Q96CU9,Q9P032,Q8N183 6 |
| Translation inhibitors in chronically activated pdgfra cells 0.3785470865641148 0.0982703726834534 0.9217176034597654 1.0 1.0 18 P28482,Q53EL6,Q15118 3 |
| Photodynamic therapyinduced ap1 survival signaling 0.3309750845893532 0.095451167665659 0.9239564756476488 1.0 1.0 7 Q16539,P20248,P06400,P04637,Q07812,P49327 6 |
| Serotonin and anxietyrelated events 0.5230343980344082 0.0933653177399104 0.9256133425653 1.0 1.0 2 P05771 1 |
| Regulation of wnt bcatenin signaling by small molecule compounds 0.3349364417374255 0.0922795276754339 0.9264759535069118 1.0 1.0 5 O14641 1 |
| Mitochondrial immune response to sarscov2 0.3376334507050518 0.088757357455743 0.9292747477018926 1.0 1.0 9 Q9H845,Q7Z434 2 |
| Molybdenum cofactor moco biosynthesis 0.5165847665847774 0.0864691176409225 0.9310935046521168 1.0 1.0 2 Q9NQX3 1 |
| Tcell receptor tcr signaling pathway 0.3684224119627566 0.0806475149268719 0.935722277795862 1.0 1.0 17 P16220,P62993,P45984,P46109,Q06124,P28482,P08670 7 |
| White fat cell differentiation 0.3831029185867793 0.0804219064368825 0.9359017045154736 1.0 1.0 3 Q04726,P16220 2 |
| Purinergic signaling 0.5095208845208895 0.0793969566611496 0.936716889234217 1.0 1.0 2 P63096 1 |
| Pdgf pathway 0.3494963593153025 0.0738999537694843 0.9410899926365892 1.0 1.0 13 Q06124,P42224,P40763,P28482 4 |
| Gaba metabolism aka ghb 0.5000000000000098 0.070636739330672 0.9436868696718016 1.0 1.0 2 P51649 1 |
| Glycosylation and related congenital defects 0.3420909673254031 0.0663544798185684 0.947095610131079 1.0 1.0 12 Q2TAA5,Q9BT22 2 |
| Fatty acid transporters 0.3130381303813093 0.0646101162141554 0.948484429967506 1.0 1.0 6 P33121,O95573,Q9UKU0,O60488,P07108 5 |
| Oncostatin m signaling pathway 0.3650354889981752 0.0613910498637669 0.951047780090569 1.0 1.0 18 P55210,P16220,P62993,P45984,P40763,Q06124,P42224,P28482 8 |
| Joubert syndrome 0.3638889870975287 0.0584311098147121 0.9534052350480802 1.0 1.0 18 Q8TD19,Q15154,P41208,Q10713 4 |
| Glioblastoma signaling pathways 0.361675646105437 0.0527929115184015 0.9578969094151446 1.0 1.0 18 P31751,Q00534,O43524,P62993,P28482 5 |
| Omega9 fatty acid synthesis 0.3031980319803259 0.0438709640749049 0.9650072603200576 1.0 1.0 6 P33121,O95573,O95864,P49327,O60488 5 |
| Envelope proteins and their potential roles in edmd physiopathology 0.3510440885327894 0.0366749684772369 0.9707441674734631 1.0 1.0 17 Q9Y2U8,O94901,P62993,P42166,P42167,P28482 6 |
| Ras and bradykinin pathways in covid19 0.3006808425290489 0.0341092611297996 0.9727900234699528 1.0 1.0 4 P28482 1 |
| Type 2 papillary renal cell carcinoma 0.3084801720240038 0.0339774319136637 0.9728951470319942 1.0 1.0 8 P11166,O14641 2 |
| Triacylglyceride synthesis 0.2978330621676172 0.0311619909048609 0.9751403520466178 1.0 1.0 4 O15228 1 |
| Biomarkers for pyrimidine metabolism disorders 0.302902877879569 0.0232446419947186 0.9814551290530492 1.0 1.0 8 Q7LG56,Q9Y606 2 |
| Vitamin b12 disorders 0.3170915136902601 0.0219375815405112 0.9824977462471648 1.0 1.0 3 Q96EY8 1 |
| Extracellular vesiclemediated signaling in recipient cells 0.2839582052858055 0.0184436286353569 0.9852849477349994 1.0 1.0 4 Q08431,P35222,P25054 3 |
| Mitochondrial complex ii assembly 0.3578009828009834 0.0155626419436042 0.987583309481684 1.0 1.0 2 P21912 1 |
| Ovarian infertility 0.3384520884520826 0.0142722640097166 0.988612767492094 1.0 1.0 2 P11802 1 |
| Notch signaling pathway 0.3114533281930095 0.0107193864624408 0.9914473308317456 1.0 1.0 11 P40763 1 |
| Pentose phosphate metabolism 0.2782277428250996 0.0032015797567478 0.9974455133058756 1.0 1.0 5 P11413 1 |
|
|
